Sagent MethylPREDNISolone Acetate Injectable Suspension Recall: Black Particulates Risk
Sagent Pharmaceuticals recalls 400mg/10mL MethylPREDNISolone Acetate Injectable Suspension vials due to potential black particulates. Affected lots manufactured in India, expiring Jan 2025. Stop using immediately.
Stop using this now
Presence of Particulate Matter: Potential for black particulates in the drug product.
Contact the company
What happened, in plain English
Sagent Pharmaceuticals is recalling a specific injectable steroid medication vial because it may contain black particles. This could cause serious injury if injected. The recall affects vials with specific lot numbers made in India. Read more at govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0499-2024
Cite this page
“Sagent MethylPREDNISolone Acetate Injectable Suspension Recall: Black Particulates Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32707-sagent-methylprednisolone-acetate-injectable-suspension-recall-black-particulates-risk. Based on FDA recall #D-0499-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0499-2024%22&limit=1).
Why it’s dangerous
Black particles in the injectable medication could cause serious injury or death when administered. Particulate matter in injectable drugs is a known hazard as it may clog blood vessels or cause tissue damage.
Who’s affected
Prescription patients using the recalled vial for steroid treatment. Those with the specific lot numbers (5100186-5100189) manufactured in India are most at risk.
How to tell if you have this one
Check for vials labeled 'MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial'. Look for lot numbers 5100186 through 5100189 made in India, expiring January 2025.
- Brand
Sagent Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the vial if you have the recalled lot numbers (5100186-5100189) manufactured in India.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0499-2024 (April 25, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0499-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.